Rentokil Initial (LON:RTO - Get Free Report)'s stock had its "sell" rating reiterated by investment analysts at Berenberg Bank in a research report issued to clients and investors on Monday,Digital Look reports. They currently have a GBX 284 price target on the stock. Berenberg Bank's target price would indicate a potential downside of 24.57% from the company's current price.
Other equities analysts have also recently issued reports about the company. JPMorgan Chase & Co. reaffirmed a "no recommendation" rating on shares of Rentokil Initial in a report on Monday, August 11th. Deutsche Bank Aktiengesellschaft raised their target price on Rentokil Initial from GBX 425 to GBX 435 and gave the stock a "buy" rating in a report on Monday, July 21st. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a GBX 440 target price on shares of Rentokil Initial in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of GBX 397.25.
View Our Latest Report on Rentokil Initial
Rentokil Initial Price Performance
Shares of Rentokil Initial stock opened at GBX 376.50 on Monday. Rentokil Initial has a one year low of GBX 306 and a one year high of GBX 427.20. The stock's fifty day moving average is GBX 366.03 and its 200 day moving average is GBX 353.35. The stock has a market cap of £9.47 billion, a P/E ratio of 2,933.82, a P/E/G ratio of 0.56 and a beta of 0.55. The company has a debt-to-equity ratio of 113.35, a quick ratio of 1.76 and a current ratio of 1.04.
About Rentokil Initial
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.